Looking to digest the latest in gastroenterology? GI Insights is here to provide updates on screening guidelines, diagnostic options, and management tools for all diseases and disorders affecting the gastrointestinal tract.
The COVID-19 pandemic has demonstrated the effectiveness of telemedicine, but will this approach still be utilized after t…
Dyspepsia affects a large number of Americans. But what exactly is dyspepsia? And how can we distinguish dyspepsia from o…
Dyspepsia affects a large number of Americans. But what exactly is dyspepsia? And how can we distinguish dyspepsia from o…
The world of healthcare continues to drastically change over the years. But what do you need to know about the variety of em…
Millions of colonoscopies are performed each year in the United States, but which indicators should we be using to measu…
The world of healthcare continues to drastically change over the years. But what do you need to know about the variety of em…
Millions of colonoscopies are performed each year in the United States, but which indicators should we be using to measu…
Racial and ethnic bias prevent patients with colorectal cancer from receiving the highest quality of care. Dr. Neil Nand…
Racial and ethnic bias prevent patients with colorectal cancer from receiving the highest quality of care. Dr. Neil Nand…
The management of motility disorders like achalasia and gastroparesis can be very complex for both patients and …
The management of motility disorders like achalasia and gastroparesis can be very complex for both patients and …
With so many treatment options currently available for moderate to severe Crohn’s disease and ulcerative colitis, how d…
Tofacitinib is a common treatment option for patients with ulcerative colitis. But it’s not without its risks. Here to …
With so many treatment options currently available for moderate to severe Crohn’s disease and ulcerative colitis, how d…
Tofacitinib is a common treatment option for patients with ulcerative colitis. But it’s not without its risks. Here to …
Now that we have therapies like vedolizumab and ustekinumab, many are wondering if there’s still a role for anti-TNFs in…
The treatment and evaluation of inflammatory bowel disease, or IBD, is continuously changing to provide the best quality…
Now that we have therapies like vedolizumab and ustekinumab, many are wondering if there’s still a role for anti-TNFs in…
The treatment and evaluation of inflammatory bowel disease, or IBD, is continuously changing to provide the best quality…
Clostridium difficile impacts many patients around the United States. How can we better diagnose and treat …